CAC-MM-001: Anti-BCMA CAR-T therapy followed by autologous stem cell transplantation and second CAR-T (CART-ASCT-CART2) in newly diagnosed multiple myeloma patients with P53 gene abnormalities.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yuntong Liu, Weiwei Sui, Lugui Qiu, Gang An
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417009514